SCHEDULE: Laurence W. Lytton Reports 6.2% Stake in Health In Tech

Laurence W. Lytton has filed a Schedule 13G, reporting beneficial ownership of 3,317,030 shares, representing 6.2% of Health In Tech, Inc.'s Class A Common Stock.

Summary

• Laurence W. Lytton has filed a Schedule 13G, indicating a significant ownership stake in Health In Tech, Inc.
• The filing reports beneficial ownership of 3,317,030 shares of Class A Common Stock.
• This ownership represents 6.2% of the total outstanding Class A Common Stock.
• The percentage is calculated based on 53,834,658 shares outstanding as of August 12, 2026, as per the company's Q2 2026 10-Q filing.
• Lytton holds shared voting and dispositive power over these shares.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership without significant new financial or strategic information.

Positives

• Laurence W. Lytton has acquired a substantial beneficial ownership stake of 6.2% in Health In Tech, Inc., suggesting confidence in the company's future prospects.
• The filing is a routine disclosure, indicating compliance with regulatory requirements for significant shareholders.

Negatives

• The filing does not provide any new financial performance data or strategic updates for Health In Tech, Inc., limiting insights into the company's operational health.
• The nature of Lytton's investment (e.g., passive vs. active) is not detailed, leaving room for speculation about his intentions.

Risks

• The filing does not explicitly mention any risks associated with the company or the investment.
• Potential future changes in Lytton's ownership stake could introduce volatility to the stock price.

Future Outlook

No specific future outlook or guidance is provided in this Schedule 13G filing, as it pertains to ownership disclosure.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that significant beneficial ownership filings like this Schedule 13G are common in the healthcare technology sector, often indicating strategic interest from investors or potential activist involvement. The filing itself does not provide operational details of Health In Tech, Inc.

Stakeholder Impact

• Shareholders: The increased ownership by a significant individual investor may influence market perception and potentially stock price volatility.
• Management: May face increased scrutiny or engagement from Laurence W. Lytton regarding company strategy and performance.

Next Steps

• Monitor future filings from Laurence W. Lytton for any changes in beneficial ownership.
• Observe Health In Tech, Inc.'s future disclosures for any strategic implications of this ownership stake.

Key Dates

Keywords

Health In Tech, Laurence W. Lytton, Schedule 13G, Beneficial Ownership, Class A Common Stock, Shareholder, SEC Filing